4.3 Article

Kiwifruit and Cancer: An Overview of Biological Evidence

Journal

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Volume 72, Issue 4, Pages 547-553

Publisher

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/01635581.2019.1650190

Keywords

-

Ask authors/readers for more resources

Kiwifruit consumption is associated with many favorable health benefits. This article is hence aimed to provide an overview on potential effects of kiwifruit on cancer development or progression. An electronic search was performed in Medline and Web of Science, for identifying original studies exploring the relationship between kiwifruit and cancer development or progression, both in vivo and in vitro. The following keywords were used: Kiwifruit OR Kiwi OR Actinidia deliciosa OR Actinidia chinensis, in combination with cancer OR malignancy OR neoplasm. Overall, 58 items could be retrieved, fifty of which were excluded since they did not fulfilled all our search criteria. Eight studies (five in vitro studies, two human intervention trials, and one both in vivo and in human study) were finally included in this critical literature review. Taken together, the results of these published studies suggest that kiwifruit supplementation may be associated with direct and indirect anticancer effects, the former likely due to ascorbic acid-mediated reduction of DNA oxidative injury and cytotoxic effect on cancer cell lines, the latter more likely attributable to enhanced daily bowel movements and increased intestinal fecal content of lactic acid bacteria, which would finally contribute to lower the risk of malignancies, especially colorectal cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Nutrition & Dietetics

Lifestyle and dietary factors, iron status and one-carbon metabolism polymorphisms in a sample of Italian women and men attending a Transfusion Medicine Unit: a cross-sectional study

Renata Bortolus, Francesca Filippini, Francesca Chiaffarino, Silvia Udali, Marianna Rinaldi, Giorgio Gandini, Martina Montagnana, Giuseppe Lippi, Oliviero Olivieri, Fabio Parazzini, Simonetta Friso

Summary: This study investigated the iron status of healthy blood donors in Italy and found that a large proportion of the subjects had adequate plasma iron and ferritin concentrations. There was a relationship between folate-related genetic polymorphisms and iron metabolism, which warrants further investigation.

BRITISH JOURNAL OF NUTRITION (2023)

Article Medical Laboratory Technology

Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept

Gian Luca Salvagno, Brandon M. Henry, Giulio Bongiovanni, Simone De Nitto, Laura Pighi, Giuseppe Lippi

Summary: This proof of concept study demonstrates the potential feasibility of using rapid diagnostic tests to gather information on viral load in patients with acute SARS-CoV-2 infection.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Article Medical Laboratory Technology

Time to address quality control processes applied to antibody testing for infectious diseases

Wayne J. Dimech, Giuseppe A. Vincini, Mario Plebani, Giuseppe Lippi, James H. Nichols, Oswald Sonntag

Summary: As testing for infectious diseases evolves, the methods for controlling these assays need to change as well. Traditional quality control methods used in clinical chemistry are not suitable for infectious disease serology due to the many differences between the two. This paper outlines these differences and provides recommendations for quality control in infectious disease serology.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Letter Otorhinolaryngology

Impact of COVID-19 pandemic on the worldwide burden of tinnitus

Riccardo Nocini, Giuseppe Lippi, Camilla Mattiuzzi

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)

Letter Medicine, General & Internal

Timeline analysis of clinical severity of COVID-19 in the general population

Camilla Mattiuzzi, Giuseppe Lippi

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Letter Hematology

Has D-Dimeritis Worsened during the Coronavirus Disease 2019 Pandemic?

Giuseppe Lippi, Valeria Perilli

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Editorial Material Hematology

Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part IV

Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Article Medicine, General & Internal

Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test

Laura Pighi, Brandon M. Henry, Simone De Nitto, Gianluca Gianfilippi, Gian Luca Salvagno, Giuseppe Lippi

Summary: This study presents a real-world assessment of the clinical performance of the COVID-VIRO ALL IN device. Although its diagnostic performance does not exactly match that of the manufacturer, it has a high negative predictive value in high viral load samples, allowing for rapid identification of highly contagious individuals.

DIAGNOSIS (2023)

Editorial Material Medicine, General & Internal

Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond

Giuseppe Lippi, Brandon M. Henry

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Editorial Material Medicine, General & Internal

COVID-19 and smoking: Considerations after two years

Giuseppe Lippi, Brandon Michael Henry, Fabian Sanchis-Gomar

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Editorial Material Medicine, General & Internal

Clinical pearls and pitfalls of SARS-CoV-2 serology

Giuseppe Lippi, Brandon M. Henry

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Review Immunology

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature

Kin Israel Notarte, Jesus Alfonso Catahay, Princess Juneire Peligro, Jacqueline Veronica Velasco, Abbygail Therese Ver, Jonathan Jaime Guerrero, Jin Liu, Giuseppe Lippi, Stefanie W. Benoit, Brandon Michael Henry, Cesar Fernandez-de-las-Penas

Summary: This systematic review aimed to assess the humoral response of hemodialysis patients post-mRNA SARS-CoV-2 vaccination. A total of nine studies met the inclusion criteria, and the results showed that hemodialysis patients developed lower antibody levels compared to the control group. These findings imply the need for robust vaccination strategies to address waning immune responses in vulnerable populations.

VACCINES (2023)

Letter Medical Laboratory Technology

Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2

Simone De Nitto, Laura Pighi, Gian Luca Salvagno, Giuseppe Lippi

ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO (2023)

Letter Medicine, General & Internal

Post-COVID or long-COVID? That is the question Reply

Giuseppe Lippi, Fabian Sanchis-Gomar, Brandon M. Henry

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2023)

Article Oncology

Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data

Brandon Michael Henry, Giuseppe Lippi, Ameen Nasser, Patryk Ostrowski

Summary: The study analyzed phase IV clinical trials in oncology from ClinicalTrials.gov registry data. It examined trials conducted from January 2013 to December 2022 for key characteristics such as outcomes, interventions, sample sizes, study design, cancer types, and regions. The analysis included 368 phase IV oncology studies. Findings showed that 50% of the studies examined safety and efficacy, 43.5% reported only efficacy outcomes, and 6.5% described only safety outcomes. Only 16.9% of the studies were powered to detect rare adverse events. Targeted therapies accounted for the majority (53.5%) of the studies, with breast and hematological cancers being the most investigated types. Limited sample sizes in phase IV oncology studies hindered the detection of rare adverse events, emphasizing the need for additional education and participation in spontaneous reporting processes.

CURRENT ONCOLOGY (2023)

No Data Available